A Dose Escalation Study of Adavosertib (MK-1775) in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001)
Clinical trial NCT00648648 · COMPLETED
Trial details
- NCT number
- NCT00648648
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-25
- Primary completion
- 2014-01-06
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.